Monografie
Inhibition von Aurora-A als neue Therapiestrategie gegen MYCN-amplifizierte Neuroblastome = Inhibition of Aurora A as a novel therapeutic strategy against MYCN-amplified neuroblastoma
- Sprache
-
Deutsch; Englisch
- Umfang
-
153 Blätter
- Identifier
-
1107208505
Thema
Hochschulschrift
Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Der Zugriff auf Teile des Objekts ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.04.2024, 08:42 MESZ
Objekttyp
- Monografie
Beteiligte
Ähnliche Objekte (12)
Inhibition von Aurora-A als neue Therapiestrategie gegen MYCN-amplifizierte Neuroblastome
Allosterische Inhibition der Proteinkinase Aurora A = Allosteric inhibition of protein kinase Aurora A
Pharmacological inhibition of monoacylglycerol lipase as a therapeutic strategy for neurodegenerative diseases
Therapeutic inhibition of the activated leukocyte integrin αMβ2 : a novel therapeutic strategy in treating myocarditis in mice
GBA-associated Parkinson: does personalized medicine work in Parkinson's disease?
Differentiation therapy of childhood neuroblastoma through selective inhibition of histone deacetylase 8
Biochemical and functional analyses of CHCHD10 mutations associated with motoneuron disease
Inhibition of antiapoptotic BCL-2 proteins as a new therapeutic strategy in rhabdomyosarcoma
Analysis of envirnonmental polycyclinc aromatic compounds and related biomarkers using GC-APLI-MS
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Development of a gene therapeutic approach to cardiomyopathy in desmin-deficient mice
Klinische und experimentelle Untersuchungen zu Behandlungsoptionen vaskulärer Netzhauterkrankungen
Inhibition von Aurora-A als neue Therapiestrategie gegen MYCN-amplifizierte Neuroblastome
Allosterische Inhibition der Proteinkinase Aurora A = Allosteric inhibition of protein kinase Aurora A
Pharmacological inhibition of monoacylglycerol lipase as a therapeutic strategy for neurodegenerative diseases
Therapeutic inhibition of the activated leukocyte integrin αMβ2 : a novel therapeutic strategy in treating myocarditis in mice
GBA-associated Parkinson: does personalized medicine work in Parkinson's disease?
Differentiation therapy of childhood neuroblastoma through selective inhibition of histone deacetylase 8
Biochemical and functional analyses of CHCHD10 mutations associated with motoneuron disease
Inhibition of antiapoptotic BCL-2 proteins as a new therapeutic strategy in rhabdomyosarcoma
Analysis of envirnonmental polycyclinc aromatic compounds and related biomarkers using GC-APLI-MS
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Development of a gene therapeutic approach to cardiomyopathy in desmin-deficient mice
Klinische und experimentelle Untersuchungen zu Behandlungsoptionen vaskulärer Netzhauterkrankungen
Inhibition von Aurora-A als neue Therapiestrategie gegen MYCN-amplifizierte Neuroblastome
Allosterische Inhibition der Proteinkinase Aurora A = Allosteric inhibition of protein kinase Aurora A
Pharmacological inhibition of monoacylglycerol lipase as a therapeutic strategy for neurodegenerative diseases
Therapeutic inhibition of the activated leukocyte integrin αMβ2 : a novel therapeutic strategy in treating myocarditis in mice
GBA-associated Parkinson: does personalized medicine work in Parkinson's disease?
Differentiation therapy of childhood neuroblastoma through selective inhibition of histone deacetylase 8
Biochemical and functional analyses of CHCHD10 mutations associated with motoneuron disease
Inhibition of antiapoptotic BCL-2 proteins as a new therapeutic strategy in rhabdomyosarcoma
Analysis of envirnonmental polycyclinc aromatic compounds and related biomarkers using GC-APLI-MS
Evaluation of FGFR1-4 as therapeutic targets in neuroblastoma
Development of a gene therapeutic approach to cardiomyopathy in desmin-deficient mice